Company Filing History:
2 out of 2,660 
1 out of 2 
1 out of 9,150 
Years Active: 1996-1998
Title: Robert L. Geahlen: Innovator in Anti-Tumor Compounds
Introduction
Robert L. Geahlen, based in West Lafayette, Indiana, is an accomplished inventor with a notable focus on pharmaceutical innovations. With two patents to his name, Geahlen's work primarily revolves around the development of polythiophene anti-tumor agents that demonstrate promising applications in cancer treatment.
Latest Patents
Among his latest innovations, Geahlen has developed novel polythiophene compounds characterized by a specific formula. These compounds, wherein n ranges from 0 to 2, along with R₂ and R₃ being optionally substituted 2-thienyl or 3-thienyl, have shown selective cytotoxic activity against transformed human cells. These compounds are not just theoretical; pharmaceutical compositions that incorporate these polythiophene derivatives have exhibited considerable chemotherapeutic potential against slow-growing tumors in tumor cell line assays. Furthermore, Geahlen outlines a method for treating patients with tumors utilizing these innovative polythiophene compounds, making significant strides in the field of oncology.
Career Highlights
Robert L. Geahlen has made substantial contributions to the scientific community through his tenure at esteemed institutions, including the University of Texas System and the International Technology Research Institute. His involvement in pioneering research has enabled the advancement of anti-tumor agent technologies that serve an essential role in current cancer therapies.
Collaborations
During his career, Geahlen has collaborated with notable professionals such as Ching-jer Chang and Chen-Tao Lee. These partnerships have enhanced the research experience and breadth of knowledge contributing to the development and refinement of his patented compounds.
Conclusion
Robert L. Geahlen stands as a prominent figure in the innovation of anti-tumor agents. His contributions are critical in the pursuit of effective cancer treatments, underpinned by his patent work on polythiophene compounds. As research in this area advances, Geahlen's inventions will likely continue to play a significant role in improving therapeutic options for patients battling tumors.